BUZZ-Traws Pharma falls after FDA puts flu drug application on clinical hold
Reuters
Yesterday
BUZZ-<a href="https://laohu8.com/S/TRAW">Traws Pharma</a> falls after FDA puts flu drug application on clinical hold
** Shares of Traws Pharma TRAW.O down 20.81% at $1.58 premarket
** Co says the U.S. FDA placed on clinical hold its investigational new drug application for tivoxavir marboxil, a single oral tablet for prevention of seasonal influenza
** Adds that FDA flagged concerns "with the mutagenicity data package" for drug in application
** Also says it filed the application to allow the government's biomedical research unit to fully review its bid for inclusion in the strategic stockpile for avian‑flu treatment
** Clinical hold does not directly impact ongoing and planned studies outside of the United States; working to mitigate issue in clinical development plan - TRAW
** TRAW shares up 74.3% YTD
(Reporting by Gnaneshwar Rajan in Bengaluru)
((Gnaneshwar.Rajan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.